Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07197541

A Self-controlled Study of Bleomycin and Pingyangmycin Injection in the Treatment of Plantar Warts

Status
Not Yet Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

All patients were treated as self-control. Half of the warts received bleomycin injection and the other half received pingyangmycin injection for 24 weeks. During the treatment period, before each injection, photos of the skin lesions must be taken, the diameter of the skin lesions must be measured, the DLQI(Dermatology Life Quality Index) and NRS scores(NRS scores) must be filled in, and adverse events must be recorded. Before the first treatment, HPV(Human Papilloma virus) virus typing is performed on the warts.

Conditions

Interventions

TypeNameDescription
DRUGBleomycin InjectionBleomycin injection treatment group: local injection treatment, once every 4 weeks.
DRUGPingyangmycin InjectionPingyangmycin injection treatment group: local injection treatment, once every 4 weeks.

Timeline

Start date
2025-10-01
Primary completion
2026-11-01
Completion
2026-11-01
First posted
2025-09-29
Last updated
2025-09-29

Source: ClinicalTrials.gov record NCT07197541. Inclusion in this directory is not an endorsement.